tradingkey.logo
tradingkey.logo
Buscar

Amneal Pharmaceuticals Inc

AMRX
Añadir a la lista de seguimiento
17.310USD
+0.020+0.12%
Cierre 06/30, 16:00ETCotizaciones retrasadas 15 min
5.52BCap. mercado
44.64P/E TTM

Más Datos de Amneal Pharmaceuticals Inc Compañía

Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.

Información de Amneal Pharmaceuticals Inc

Símbolo de cotizaciónAMRX
Nombre de la empresaAmneal Pharmaceuticals Inc
Fecha de salida a bolsaNov 18, 2009
Director ejecutivoPatel (Chintu)
Número de empleados8100
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 18
Dirección400 Crossing Boulevard, 3rd Floor
CiudadBRIDGEWATER
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal08807
Teléfono19089473120
Sitio Webhttps://amneal.com/
Símbolo de cotizaciónAMRX
Fecha de salida a bolsaNov 18, 2009
Director ejecutivoPatel (Chintu)

Ejecutivos de Amneal Pharmaceuticals Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Chintu Patel
Mr. Chintu Patel
Co-Chief Executive Officer, Co-Founder, Director
Co-Chief Executive Officer, Co-Founder, Director
26.14M
+2.01%
Mr. Gautam Patel
Mr. Gautam Patel
Director
Director
1.64M
+2.12%
Mr. Anastasios G. (Tasos) Konidaris
Mr. Anastasios G. (Tasos) Konidaris
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
449.43K
-38.37%
Ms. Nikita Shah
Ms. Nikita Shah
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
399.79K
+52.12%
Mr. Shlomo Yanai
Mr. Shlomo Yanai
Independent Director
Independent Director
320.80K
+10.85%
Ms. Deborah M. (Deb) Autor
Ms. Deborah M. (Deb) Autor
Independent Director
Independent Director
93.66K
--
Buchi (J Kevin)
Buchi (J Kevin)
Independent Director
Independent Director
--
--
Mr. Andrew S. Boyer
Mr. Andrew S. Boyer
Executive Vice President, Chief Commercial Officer - Generics
Executive Vice President, Chief Commercial Officer - Generics
--
--
Mr. Chirag Patel
Mr. Chirag Patel
President, Co-Chief Executive Officer, Co-Founder, Director
President, Co-Chief Executive Officer, Co-Founder, Director
--
--
Mr. Ted Nark
Mr. Ted Nark
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Chintu Patel
Mr. Chintu Patel
Co-Chief Executive Officer, Co-Founder, Director
Co-Chief Executive Officer, Co-Founder, Director
26.14M
+2.01%
Mr. Gautam Patel
Mr. Gautam Patel
Director
Director
1.64M
+2.12%
Mr. Anastasios G. (Tasos) Konidaris
Mr. Anastasios G. (Tasos) Konidaris
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
449.43K
-38.37%
Ms. Nikita Shah
Ms. Nikita Shah
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
399.79K
+52.12%
Mr. Shlomo Yanai
Mr. Shlomo Yanai
Independent Director
Independent Director
320.80K
+10.85%
Ms. Deborah M. (Deb) Autor
Ms. Deborah M. (Deb) Autor
Independent Director
Independent Director
93.66K
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Amneal Pharmaceuticals Inc?

Los cinco principales accionistas de Amneal Pharmaceuticals Inc son: Mr. Chintu Patel

¿Cuántas instituciones poseen acciones de Amneal Pharmaceuticals Inc (AMRX)?

A fecha de 2026Q1, 521 instituciones poseen acciones de Amneal Pharmaceuticals Inc, con un valor de mercado combinado de aproximadamente 161.64M, lo que representa el 50.67% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -25718515.00.

¿Cuál es la mayor fuente de ganancias de Amneal Pharmaceuticals Inc?

El 2026Q1, el segmento empresarial Oral solid generó la ganancia más alta para Amneal Pharmaceuticals Inc, ascendiendo a 726.38M y representando el 24.06% de la ganancia total.
KeyAI